Information  X 
Enter a valid email address

Seed Innovations Ltd (SEED)


Friday 20 August, 2021

Seed Innovations Ltd

Updated Key Information Document

RNS Number : 1996J
Seed Innovations Limited
20 August 2021

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

20th August 2021

SEED Innovations Ltd ("SEED" or the "Company")

Updated Key Information Document


SEED Innovations Ltd, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space, is pleased to announce that the Company has prepared an updated Key Information Document ("KID") which can now be viewed on SEED's website via the following link:


  For further information on the Company please visit   or contact:

Ed McDermott /

Lance de Jersey

SEED Innovations Ltd

Email:      [email protected]


James Biddle /

Roland Cornish

Beaumont Cornish Limited,



Tel: +44 (0) 207 628 3396

Isabella Pierre /

Damon Heath

Shard Capital Partners LLP


T: +44 (0)20 7186 9927

Catherine Leftley /

Isabel de Salis

St Brides Partners Ltd,

Financial PR


Email:  [email protected]



SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t